Profile: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,431.00GBp
7:47am EDT
Price Change (% chg)

8.00p (+0.56%)
Prev Close
1,423.00p
Open
1,428.00p
Day's High
1,433.50p
Day's Low
1,424.00p
Volume
3,366,916
Avg. Vol
7,730,644
52-wk High
1,733.00p
52-wk Low
1,410.89p

Search Stocks
GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and human immunodeficiency virus (HIV). The Company operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. On January 30, 2013, GSK acquired additional 29.3% interest in GlaxoSmithKline Consumer Healthcare Ltd. In May 2013, GlaxoSmithKline PLC acquired Okairos AG. In December 2013, Suntory Beverage & Food Ltd fully acquired Lucozade Ribena Suntory Limited from GlaxoSmithKline plc.

Company Address

GlaxoSmithKline PLC

C8 Gsk House, 980 Great West Roa
BRENTFORD   ENG   TW8 9GS
P: +4420.80475000
F: +4420.80477807

Search Stocks